Cost Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in Colombia

OBJECTIVES: The aim of this study was to evaluate the cost effectiveness of mirabegron relative to two antimuscarinics, oxybutynin extended release (ER) and tolterodine ER, in patients with overactive bladder (OAB) from the perspective of a third-party payer in Colombia. METHODS: A Markov model simu...

Descripción completa

Detalles Bibliográficos
Autores principales: Parise, Hélène, Espinosa, Robert, Dea, Katherine, Anaya, Pablo, Montoya, Giovanny, Ng, Daniel Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018934/
https://www.ncbi.nlm.nih.gov/pubmed/31168754
http://dx.doi.org/10.1007/s41669-019-0149-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018934/
https://www.ncbi.nlm.nih.gov/pubmed/31168754
http://dx.doi.org/10.1007/s41669-019-0149-9

Ejemplares similares